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Abstract: This review contains an account of recent developments in the applications of N’-
monoalkylated or N’-mono(thio)acylated(N-sulfonyl)-1,2-diphenylethylene-1,2-diamine 
(TsDPEN) derivatives to asymmetric catalysis. The coverage features examples of applications 
of derivatives as ligands in organometallic complexes for use in asymmetric reduction and 
oxidation reactions. The use of TsDPEN derivatives as catalysts in a diverse range of C-C and 
C-S bond formation reactions is also described in detail.
1. Introduction. 
N-(p-Tosyl)-1,2-diphenylethylene-1,2-diamine (TsDPEN) 1 (Figure 1) is a widely used chiral 
diamine derivative with synthetic applications in asymmetric catalysis. The precursor to 1, i.e. 
1,2-diphenylethylene-1,2-diamine 2 (Figure 1), can be readily prepared in both 
enantiomerically pure forms. This can be achieved through the reaction of benzil with 
cyclohexanone and ammonium acetate to initially form a spiro-bicyclic diimine intermediate 
which is then reduced with metallic lithium and hydrolysed to give the racemate, subsequently 
resolved through the formation of its tartaric acid salt.[1a,1b] Enantiomerically-pure DPEN 
may also be prepared via the diol precursor, itself generated using a Sharpless asymmetric 
dihydroxylation reaction.[1c,1d] Enantiomerically-pure DPEN itself has found extensive 
applications as a component of asymmetric organometallic catalysts, and for ketone 
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2hydrogenation in particular.[2] TsDPEN, and other sulfonylated derivatives, may then be 
prepared through an efficient monotosylation of the diamine.
TsHN NH2
Ph Ph
H2N NH2
Ph Ph
(R,R)-TsDPEN-1 (R,R)-DPEN-2
Figure 1. Structures of (R,R)-TsDPEN and DPEN.
Perhaps the most successful and established application to catalysis of TsDPEN is as a ligand 
in [6-arene)Ru(II)TsDPEN(Cl)] complexes such as 3a-3d (Figure 2), which are now 
established as efficient and selective catalysts for asymmetric transfer hydrogenation (ATH) of 
ketones and imines.[3] In ATH applications, the simple preparation of the derived catalysts by 
the reaction of TsDPEN with an 6-arene ruthenium(II) chloride dimer precursor makes the 
reagents highly practical. Derivatives containing alternative sulfonamide groups have also been 
reported. In contrast, very few examples of catalysis by N’-monofunctionalised TsDPEN 
derivatives (i.e. containing a single alkyl or acyl group on the non-sulfonylated amine) have 
been reported, which is surprising given the potential for modification of the properties of the 
catalyst whilst retaining a basic nitrogen functionality and NH-bonding potential in the likely 
catalytic cycles. 
Ru
TsN NH2
Ph Ph
Cl
3b
iPr
Ru
TsN NH2
Ph Ph
Cl
3a
Ru
TsN NH2
Ph Ph
Cl
3c
Ru
TsN NH2
Ph Ph
Cl
3d
Figure 2. Asymmetric transfer hydrogenation (ATH) catalysts derived from (R,R)-TsDPEN.
Hence this review will specifically summarise developments in the use of N’-monoalkylated 
TsDPENs 4 and N’-(thio)monoacylated TsDPENs 5, and related derivatives containing 
alternative sulfonamide substituents (Figure 3). However the coverage will not include 
‘tethered’ complexes such as 6 as these have been reviewed previously.[4] Dialkylated 
TsDPEN derivatives will not be discussed, although some examples of their applications have 
been reported.[5]. Likewise, the applications of TsDPEN derivatives linked to an N’-imine or 
imidazoline will also not be described.[6] 
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3NH HN
Ph Ph
R
N'-monoalkylated, N-
sulfonylated DPENs 4
NH HN
Ph Ph
X
R
O2SO2S
R' R'
Ru
N NTs
Ph Ph
Cl
H
N N
Ph Ph
O2S
R'NH NR2
Ph Ph
N',N'-dialkyl
derivatives
O2S
R'
R
Coverage in this review:
NH N
Ph Ph
O2S
R' R
Imine
derivatives
N'-mono(thio)acyated, N-
sulfonylated DPENs 5
X=O or S
Not covered in this review:
tethered catalysts 6
Imidazoline
derivatives
Figure 3. N’-monoalkylated and N’-mono(thio)acylated TsDPEN derivatives will be 
reviewed. 
2. Use of N-alkylated TsDPEN in asymmetric transfer hydrogenation and hydrogenation:
In one of the earliest papers on ATH by Noyori et al. [3f] in which formic acid/triethylamine 
(FA/TEA) was used in the reduction, some specific observations were made on the importance 
of the electronic and steric nature of both the 6-arene ring and the diamine. In terms of 
reactivity, complexes with an 6-benzene (3a) were found to be the most reactive, followed by 
p-cymene and mesitylene (3b, 3c) and finally hexamethylbenzene complexes (3d) were the 
least reactive. However the mesitylene and p–cymene-containing complexes 3b and 3c gave 
the best reduction enantioselectivities. More significantly, it was stated that the presence of the 
primary amine in the TsDPEN part was highly important and that ‘the NHCH3 analogue 
showed a comparable enantioselectivity but with much lower reactivity; the N(CH3)2 derivative 
gave very poor reactivity and stereoselectivity.’. In light of the accepted mechanism by which 
the hydride derivatives of catalysts 3a-d are believed to operate[2e,3], in which an N-H bond 
is essential, this is unsurprising. In 2011, Wills et al prepared and isolated the N’Me2 derivative 
of 3a and confirmed that it was a very poor catalyst for ketone ATH, but was effective at imine 
reduction (although products of low ee were formed), suggesting a different mechanism for 
imine reduction.[7].
In 2004, Ikariya and Koike reported a study on the rates of formation of formate derivatives of 
3a-3d (i.e. with a formate in place of Cl) from the corresponding ruthenium hydrides upon 
reaction with carbon dioxide [8]. Although most studies were focussed on the parent TsDPEN-
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4derived complexes, an N’-methylated derivative was also studied, and the rates were 
comparable. However the ruthenium hydride with two N’ methyl groups, did not form the 
formate, indicating that the N-H bond was essential to the mechanism. 
In 2009, Wills et al. reported a systematic study on N-alkylated TsDPEN derivatives 7 (Figure 
4).[9] It was found that systematic variation of the alkyl group has some measurable effects, 
notably that addition of a methyl group actually generated a more active catalyst, and that the 
addition of linear alkyl chains has no detrimental effects on the catalysis of ATH of ketones or 
imines. The addition of more bulky chains reduced the activity of the complexes, although the 
ees were not significantly affected. An important observation was that the use of the 6-benzene 
ring in the complexes was essential; complexes containing a substituted arene did not work 
effectively as catalysts, presumably due to the increased steric hindrance. The sense of 
reduction of the cyclic imine which was tested with these and other derivatives suggested that 
an open transition state is operating, rather than the more established ketone reduction 
transition state in which the operation of a hydrogen bond from the N-H to the ketone is 
essential.
Ru
TsN N
Ph Ph
Cl
R
H
7
R=Me, Et, Pr,
Bn, iBu, (CH2)2Ph
O OH
N NH
Rate order:
R=Me>Et>H>Pr>iBu=Bn=(CH2)2Ph
H; 95% ee, Me; 96% ee, Et; 96% ee,
nPr; 96% ee, iBu; 98% ee, Bn; 95%
ee, (CH2)2Ph 96% ee
1 mol% cat 7
FA/TEA,
28 oC
1 mol% cat 7
FA/TEA,
28 oC
Rate order:
R=Me>H>Et>Pr=iBu>Bn>(CH2)2Ph
H; 80% ee, Me; 75% ee, Et; 79% ee,
nPr; 79% ee, iBu; 79% ee, Bn; 85% ee,
(CH2)2Ph 70% ee
Figure 4. A series of N’-alkylated TsDPEN complexes which were effective at ATH of ketones 
and imines.
 
Having the ability to add a functional group to the basic nitrogen atom of TsDPEN without 
detrimentally affecting the catalytic properties of the complexes potentially allows for 
moderation of activity towards specific targets and a means to link the catalysts to a functional 
group which can moderate its properties e.g. with respect to solubility. Further examples of 
what could be tolerated at the ‘basic’ nitrogen atom were reported by Wills et al. and are 
illustrated in Figure 5.[10,11,12] It was found that several functionalised N’-benzyl groups 
Page 4 of 36Organic & Biomolecular Chemistry
O
rg
an
ic
&
B
io
m
ol
ec
ul
ar
C
he
m
is
tr
y
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
04
 Ja
nu
ar
y 
20
19
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f W
ar
w
ic
k 
on
 1
/4
/2
01
9 
3:
42
:2
8 
PM
. 
View Article Online
DOI: 10.1039/C8OB02889C
5could be added without significantly altering the catalytic and enantioselective properties of 
the reagents in ketone and imine reduction. Although acetophenone reduction and the reduction 
of a dimethoxydihydroisoquinoline proceeded in good ee, reductions of cyclic imines lacking 
a fused aromatic ring were much less enantioselective (Figure 4)[10], and these remain an 
ongoing challenge. A chain to a hydroxyl group could be added without reducing the 
enantioselectivity of the catalyst.[11] Other groups which could be added include anthracene 
and a tri(BIPY)Ru complex (Figure 5), to give complexes which were all still competent in the 
reduction of ketones, underlining a high level of tolerance of functionality at the basic nitrogen 
atom of the complex.[12]
Ru
TsN N
Ph Ph
Cl
H Rn
Ru
TsN N
Ph Ph
Cl
H
CO2Me/H
Ru
TsN N
Ph Ph
Cl
H
Ru
TsN N
Ph Ph
Cl
H
N
N
N
N
N
N
Ru
2 Cl
Figure 5. Examples N’-Alkylated TsDPEN derivatives which have been used in ATH of 
ketones and imines.
In an example published in 2015,[13] a tetraarylphosphonium (TAP)-functionalised ligand was 
prepared and converted to a Ru(II)-based catalyst 8 which was subsequently applied to the 
ATH of ketones in water (Figure 6). The salt was catalytically effective and a range of ketones 
were reduced in aq. FA/TEA (a 1.2:1.0 ratio was found to be optimal). Using this catalyst at 
40 oC, a good number of ketones could be reduced in high ee and conversion. The catalyst 
could also be recycled and reused a number of times by precipitation from solution using ether, 
thus taking advantage of the modified solubility properties of the catalyst, which also proved 
to be very stable.
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6Ru
TsN N
Ph Ph
Cl
H
iPr
PPh3
ClO4
Run no.
1
2
3
4
5
Acetophenone reduction
(aq. FA/TEA 1.2:1, S/C=100)
time/h
7
7
7
16
36
conv/%
>99
>99
>99
>99
75
ee/%
94.7
95.0
95.2
94.9
92.1
TAP-Ru-TsDPEN 8
OHCl
14h, >99% conv.
89.6% ee (R)
Products of ketone reduction (40 oC, aq. FA/TEA 1.2:1, S/C=100)
using TAP-Ru-TsDPEN 8
OH
4h, >99% conv.
91.1% ee (R)
Cl
OHBr
7h, >99% conv.
89.9% ee (R)
OH
5h, >99% conv.
91.7% ee (R)
Br
OH
14h, >99% conv.
95.5% ee (R)
MeO
OH
n=1; 7h, >99% conv.
98.1% ee (R)
n=0; 5h, >99% conv.
96.8% ee (R)
n
X OH
X=O; 14h, >99% conv.
95.8% ee (R)
X=S; 14h, >99% conv.
95.5% ee (R)
Figure 6. Use of a tetraarylphosphonium (TAP)-functionalised catalyst 8 in the asymmetric 
reductions of ketones.
Examples have been reported of ATH catalysts supported on heterogeneous supports.[14] The 
catalyst (9) in the report by Ma et al. is linked through both groups to a phosphate-
functionalised polystyrene support (Figure 7).[15] The subsequent reaction of this to form an 
inorganic zirconium phosphate-phosphonate created a ‘pillared’ structure which could be 
separated after each catalytic use (using formic acid/trimethylamine in aqueous solution) by 
centrifugation and washing, and recycled. Throughout the recycling, the ee remained high, over 
five cycles, although there was evidence of some leaching of catalytic material from the system. 
Using the catalyst in aqueous solution permitted the reduction of a range of ketones in excellent 
conversions (yields >90% in most cases) and high ee. 
Ru
N N
Ph Ph
Cl
H
9
iPr
Ph PO3H
Ph
HO3P
O2
S
n
m
n
m
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7Figure 7. A polystyrene-supported catalyst which was encapsulated into a zirconium 
phosphate-phosphonate inorganic support.
Touge reported the synthesis and applications of arene/Ru/TsDPEN complexes such as 10 
containing boronic acid groups attached to the basic nitrogen atom [16], and these are reported 
to form effective catalysts for asymmetric reductions (Figure 8A). A catalyst derived from an 
N’-phosphoric acid-functionalised TsDPEN derivative was also reported.
Ru
TsN N
Ph Ph
Cl
H
10
iPr
Ru
TsN N
Ph Ph
Cl
H
11
iPr
O
O
OH/Me
n
O OH
n n
n=2, 98% conv, 99% ee
n=1 97% conv. 99% ee
Ru
TsN N
Ph Ph
Cl
H
12
X
N
NN
Y
Reduction of acetophenone with 12
(FA/TEA 5:2, 1 mol% catalyst, 28 oC).
A Boronic-acid functionalised (arene)Ru complex:
B (arene)Ru complex containing PEG-ligand for aqueous solubility:
C (arene)Ru complex containing link via remote triazole group:
X
O
CH2
CH2
Y
(CH2)2OBn
Bn
methacrylate polymer
time/h
136
71
24-144
conv/%
99
97
up to 100
ee/%
96
95
90-95
B(OH)2
Reduction of cyclic ketones with 11
(HCO2Na, H2O, 1 mol% catalyst, rt).
Figure 8. Modified arene/Ru/TsDPEN catalysts containing links to the N’-nitrogen atom of 
the TsDPEN ligand.
A series of modified TsDPEN-containing ligands bearing N’-PEG chains (200-2000 Daltons) 
were prepared by Li et al. through a reductive amination of the PEG aldehyde with TsDPEN 
(Figure 8B).[17] These modified ligands worked effectively in aqueous transfer hydrogenation 
of ketones using sodium formation as the reducing agent. A range of ketone reductions were 
reported and, more significantly, the PEG-based catalysts could be reused multiple times by 
extracting the reduction product from solution using hexane, then adding fresh formic acid and 
substrate. A similar reagent, attached through formation of a triazole, to a soluble polymer 
Page 7 of 36 Organic & Biomolecular Chemistry
O
rg
an
ic
&
B
io
m
ol
ec
ul
ar
C
he
m
is
tr
y
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
04
 Ja
nu
ar
y 
20
19
. D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
ity
 o
f W
ar
w
ic
k 
on
 1
/4
/2
01
9 
3:
42
:2
8 
PM
. 
View Article Online
DOI: 10.1039/C8OB02889C
8made from methacrylate units, was also reported and demonstrated to be almost as effective as 
the unsubstituted reagents (Figure 8C).[18]
Touge and Arai investigated the asymmetric hydrogenation, i.e. using hydrogen gas rather than 
ATH, of a series of challenging indole substrates using arene/Ru/TsDPEN catalysts [19] and 
were encouraged by the observation made previously [8,9] that addition of the methyl group to 
the basic nitrogen atom of the ligand resulted in the formation of a more active catalyst. Indeed 
this modification led to the preparation of cationic catalyst 13 which exhibited a much higher 
level of activity and was able to catalyse the reduction of 2-methyl indole with full conversion 
and high ee within a few hours using 5 bar or less hydrogen and at 10 oC (Figure 9). The use 
of cationic catalyst, i.e. where the ‘Cl’ is replaced by BF4 or TfO or some other bulky anion, 
has already been demonstrated to be important for the catalysis of hydrogenation, however the 
equivalent non N’-methylated catalyst was less reactive. 
The catalyst was also successfully applied to the reduction of a range of mono and di-
substituted (at the indole) substrates (Figure 9), giving the reduced products in high yields and 
enantioselectivities. 2,3-Disubstituted products were formed as the cis-diastereoisomers, 
whether cyclic or acyclic with respect to the newly-formed saturated ring. In each case the 
yields and ees were high and in one case the S/C was as high as 2000.
Ru
TsN N
Ph Ph
BF4
Me
H
13
iPr
N
H NH
5 bar H2, 10 oC
7 h, HFIP
S/C 500, catalyst 13
R
N
H
R2
N
H
R2
5 bar H2, 0-30 oC
23-31 h, HFIP
S/C 100-2000, catalyst 13
R1 R1
>99% yield
96.2 % ee
Major product using
(R,R)-catalyst.
R1=R2=Me or
R1-R2 = (CH2)3 or (CH2)4
yield >99% in best cases
91-99% ee
N
H
OR
R=TBS: Using (S,S)-13:
94% yield, 92% ee
(30 oC, 7h)
R=Bn: Using (S,S)-13:
94% yield, 84% ee
(30 oC, 7h)
N
H
Using (S,S)-13:
90% yield, 90% ee
(30 oC, 7h)
O
O
N
H
CO2R
n=2, R=Et: Using (S,S)-13:
95% yield, 91% ee
(10 oC, 30h)
n=0, R=Me: Using (S,S)-13:
91% yield, 72% ee
(30 oC, 27h)
n
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9Figure 9. Asymmetric reduction of indoles using the N’-methylated cationic complex 13; the 
non-N’-methylated complex was less active. 
Halogenated indoles and substrates containing sensitive protecting groups such as benzyloxy 
and acetals were also selectively hydrogenated without damage to the functionality, allowing 
a series of post-reduction functionalisations to be carried out, such as Pd-catalysed coupling 
reactions. 1,1,1,3,3,3-Hexafluoroisopropanol (HFIP) was identified as the best solvent in these 
reductions and could be recovered and reused. 
In the same year (2016), Fan et al independently reported their results on indole hydrogenation 
using the triflate analogue 14 of the N’-methylated catalyst, which proved to be the best out of 
a series of catalysts tested [20]. Again the reductions could be achieved in high conversion and 
ee at ambient temperature and 1 atmosphere of hydrogen using S/C of 100. The catalyst was 
however also effective at an S/C of 1000, with only a small loss of enantioselectivity. Using 
the (R,R) catalyst, the product of R- configuration was formed and disubstituted compounds 
were formed as the cis products (Figure 10). In addition, Fan et al. reported the reduction of 
imines containing a 3,3-disubstituted structure, which also proceeded in high ee and 
conversion, although in this case the Ru complex containing an unsubstituted basic amine, and 
either a triflate or a phosphate counter ion, proved to be the best catalyst. Likewise the same 
unfunctionalised catalyst was effective at the kinetic resolution of certain examples. 
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10
Ru
TsN N
Ph Ph
OTf
Me
H
14
iPr
N
H
R1
N
H
R1
1 bar H2, rt
24 h, HFIP
1 mol% 14
N
R2
N
H
R2
R1 R1R1
R1
N
H
R
R2
X
R2
X
R=Me; 94% yield, 96% ee (R)
R=nPr; 88% yield, 96% ee (R)
R=nBu; 92% yield, 97% ee (R)
R=n-Pent; 89% yield, 96% ee (R)
N
H
Me
X
X=Me; 93% yield, 95% ee (R)
X=OMe; 93% yield, 95% ee (R)
X=F; 94% yield, 94% ee (R)
N
H
R=H; 93% yield, 97% ee (R)
R=F; 92% yield, 97% ee (R)
R=Me; 90% yield, 96% ee (R)
R
N
H
X
n
n=0, X=H, 92% yield, 89% ee (R,R)
n=1, X=H, 91% yield, 95% ee (R,R)
n=1, X=Me, 94% yield, 90% ee (R,R)
n=1, X=F, 92% yield, 94% ee (R,R)
n=2, X=H, 73% yield, 99% ee (R,R)
N
H
85% yield, 40% ee (R)
N
H
53% yield, 42% ee (S)Ph
N
H
95% yield, 97% ee (R,R)
1 bar H2, rt
24 h, HFIP
or THF
1 mol% 14
Other reduction products formed using 14:
Figure 10. Asymmetric reduction of indoles using the N’-methylated cationic complex 14; the 
non-N’-methylated complex was more effective in the latter application. 
Fan et al. also reported the asymmetric hydrogenation of 2,2’-bisquinolines to form vicinal 
diamines using a series of [arene/Ru/TsDPEN] catalysts including 14-16 [21] (Figure 11). In 
several cases, the N’-methylated catalyst proved to be the best one in the application, although 
in others the unmethylated complex was better. An N’-benzyl complex 15 was tested but did 
not give improved results. Although the parent unsubstituted product is illustrated in Figure 11, 
a very wide range of substrates were tested, giving products in excellent yield and ee 
throughout; in the majority of cases the N’-Me catalyst was the most effective and gave the 
best result, although in some cases the unmethylated complex was slightly more efficient. In a 
series of mechanistic studies, including reduction of the enantiomerically pure semi-reduced 
product with each enantiomer of catalyst, it was established that the second reduction occurred 
with high diastereoselectivity, and was essentially fully controlled by the catalyst and not 
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significantly directed by the existing chiral centre. The products could be converted to 
derivatives such as the interesting asymmetric imidazolium salt 17.
 
50 atm H2
rt 18h, iPrOH
S/C 50, catalyst
N N NH HN
Ru
TsN N
Ph Ph
OTf
Me
H
14 >95% conv.
iPr
Ru
TsN N
Ph Ph
OTf
Bn
H
iPr
Ru
TsN N
Ph Ph
OTf
H
H
iPr
93:7 dl:meso
>99% ee
15 >95% conv.
93:7 dl:meso
>99% ee
16 >95% conv.
90:10 dl:meso
>99% ee
N N
BF4 17
R R
Figure 11. Asymmetric reduction of bis-quinolines using the cationic complexes 14-16. 
The asymmetric reduction of C=C bonds using arene/Ru(II)/TsDPEN catalysts has not been 
extensively reported however the example by Deng et al. contains some very good examples 
of selective reductions on highly activated alkenes. Usually two (non-ketone) electron-
withdrawing groups are required for best results (Figure 12).[22] The N-methylated and N-
ethylated ligands were used to form complexes in-situ. These worked effectively in the 
application but in this instance gave no improvement over the unsubstituted complex. The best 
results were obtained using TsDPEN catalysts containing modified sulfonamide groups; bulky 
groups being the most effective.
TsHN N
Ph Ph
Me
H TsHN N
Ph Ph
Et
H TsHN N
Ph Ph
H
H
3.5h, 97% yield
52% ee
10h, 96% yield
47% ee
4h, 98% yield
61% ee
NC CN Ligand + [(cymene)RuCl2]2
(catalyst formed in situ)
FA/TEA, 30 oC, THF
NC CN
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Figure 12. Asymmetric C=C reduction using arene/Ru(II) complexes formed from a series of 
TsDPEN ligands.
In some cases, TsDPEN-derived ligands can act in a tridentate fashion, with triazole and 
pyridine functionality (in 18 and 19 respectively) added to the TsDPEN, catalytically efficient 
complexes are formed with Ru3(CO)12. These reduce acetophenone derivatives at elevated 
temperatures in high ee using iPrOH as both the solvent and reducing agent, and in the absence 
of base (Figure 13).[23,24] The inclusion of both the tosyl and the triazole are essential for 
high activity with the ruthenium carbonyl reagent. A range of ketones were reduced in good ee 
(over 90% in the best cases) and notably ortho-substituted examples, which are often 
challenging substrates, gave products of high ee in the reductions. Both complexes are believed 
to form active ruthenium hydride complexes of a general structure similar to 20 (illustrated for 
the triazole derivative) which may be able to engage in hydrogen transfer to the ketone substrate 
through a transition state analogous to the Noyori-Ikariya [arene/Ru/TsDPEN] complexes 
described above.
Ru
TsN N
Ph Ph
N
H
20
O OH
1 mol% 18 or 19
iPrOH, 24h
TsN HN
Ph Ph
NBn
N
N
TsN HN
Ph Ph
N
N NBn
H
OC
CO
18
19
18 (triazole) up to 99% conv, 91% ee
X
X
0.33 mol% Ru3(CO)12
((2-OMe in 98% conv, 85% ee)
19 (pyridine) up to 100% conv, 94% ee
((2-OMe in 99% conv, 89% ee)
80 oC
Figure 13. Application of tridentate derivatives of TsDPEN/Ru3(CO)12 to ATH of ketones.
Several N-alkylated ligands, with simple iridium trichloride salts, have been applied to the 
asymmetric hydrogenation of ketones in good ees, the alkyl group offering the opportunity to 
optimise the ee to some extent.[25,26] An ‘N’,N’-diTsDPEN bridged derivative has been 
prepared and used in a Ni complexes in the ATH of acetophenone.[27,28] A related 
bisTsDPEN, with a phosphine between diamines, has been used with an Ir(I) source in 
propiophenone reduction. In this application, in iPrOH/KOH, products were formed in ees of 
up to ca. 75% when IrCl(COD)(PPh3)2 was used as the Ir source.[29] 
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3. Use of N-alkylated TsDPEN in asymmetric oxidation reactions. 
In 2007, Beller et al. reported the use of a N’-benzylated TsDPEN 21 for the asymmetric 
epoxidation of 1,2-disubstituted alkenes using FeCl3 as the metal.[30] This proved to be the 
best ligand of a series tested, and an improvement over TsDPEN itself, which gave a product 
of just 28% ee compared to the 47 % obtained using 21 (Figure 14). Application of the 
methodology to a range of substrates revealed that products of higher ees could be obtained; 
up to 97% ee for one substrate with the use of a slightly higher catalyst loading. This remains 
one of the few reported methods for asymmetric epoxidation reactions using a simple iron(III) 
salt and amine-based ligand. A detailed follow up paper by the same authors revealed that the 
system was also effective for the asymmetric epoxidation of monosubstituted alkenes, notably 
styrene derivatives, and further disubstituted substrates containing diverse substitutions.[31] A 
full mechanistic investigation using ESI-MS, UV-Vis and EPR spectroscopy indicated the 
presence of several iron complexes forming in situ and the formation of radical intermediates. 
An extension of the work using TsDPEN attached to multifunctional ligands e.g. 22 was 
reported in 2013 (Figure 14), which revealed an excellent level of reactivity and excellent 
selectivity in the best cases (up to 91% ee for stilbenes).[32] The larger size of the ligands 
provided a method for their recovery and reuse via precipitation and also through phase 
separation.
TsHN NHBn
Ph Ph
TsHN HN
Ph Ph
R2
R1
5 mol% FeCl3.6H2O
5 mol% H2pydic
12 mol% 21
2-methylbutan-2-ol, rt, 1h
O
Si
Si
422
+ 3 eq. H2O2
tButBu
100% conv, 82% ee
R2
R1 O
major product
(47% ee where R1=R2=Ph)
O
60% conv, 57% ee O
tBu
100% conv, 97% ee
(using 24 mol% catalyst 21)
21
O
OH
tBu
100% conv, 49% ee
O
Cl
tBu
57% conv, 33% ee
Epoxidation products formed using ligand 21:
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Figure 14.  Epoxidation of alkenes using an iron catalyst with an N’-benzyl TsDPEN ligand, 
and a dendrimeric derivative.
Malkov et al reported the use of a TsDPEN derived reagent 23 for the asymmetric epoxidation 
of allylic alcohols as a component of a vanadium-catalysed reaction, giving products of up to 
94% ee (Figure 15) [33]. Also pertinent to the area is work by Xiao on the use of the Fe catalyst 
24 for the catalysis of the oxidation of benzylic ethers to esters using oxygen gas as the oxidant 
(Figure 15).[34a] A closely related Fe(III) catalyst is also effective at the oxidative cleavage of 
C=C bonds (not illustrated).[34b]
TsHN N
Ph Ph
23 TsDPEN-derived ligand used in
vanadium-catalysed oxidation.
HO O
CHPh2
24 Fe catalyst for oxidation of benzylic
ethers to esters using O2
N
N
N
H
N
H
N
SO2ArArO2S
PhPh
Ph
Fe
THF
TfO OTf
Ar = p(tBu)C6H4
Figure 15. TsDPEN-derived ligand and iron complex used as catalysts. 
4. Use of N-alkylated TsDPEN in asymmetric organocatalytic reactions.
Several N’-functionalised derivatives of TsDPEN have been used in organocatalytic 
applications. An early example described the use of an enzyme mimic catalyst containing an 
amide, urea and TsDPEN-linked unit for the control of amine additions to cyclic unsaturated 
6-membered lactams. These were cleverly designed to bind at several positions to the 
substrates; several catalyst variations were tested including those containing a TsDPEN unit, 
and addition products of up to 62% ee were obtained.[35]
Ye et al. have reported a series of applications of TsDPEN-derived organocatalysts containing 
a primary amine, initially for control of asymmetric Michael additions of unsaturated lactones 
to enones (Figure 16).[36] In the examples shown, the enones contained alkyl or aryl 
substituents and gave products in very high ee. One example of a cyclic enone was featured 
and this was formed in 51% yield but still high ee (97% ee).
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TsHN HN
Ph Ph
R1 R2
O
+ O
O
R1 R2
O
O
O
H
H
iPr
H2N
CHCl3
acyclic compound:
65-86% yield
95-99% ee
50 oC, 72h
R1 = alkyl, aryl
R2 = aryl/alkyl
Figure 16. Asymmetric addition of unsaturated lactones to enones.
The use of an amine-containing TsDPEN to control the addition of a cyclic unsaturated lactam 
to an enone has been reported; the addition of N-Boc-L-Tryp was found to be essential for high 
enantioselectivity in the reaction (Figure 17).[37] The mechanism is reported to proceed via 
the formation of an enamine between the primary amine of the ligand and the enone, with 
addition of the enol form of the unsaturated lactam being directed by hydrogen bonding 
interactions with the tosylated diamine.
TsHN HN
Ph Ph
O
+ NBoc
O
O
BocN
O
H
H
iPr
H2N
CHCl3
N-Boc-L-Trp
15:1 98% ee
Figure 17. Asymmetric additions of cyclic lactam to an enone.
The use of the ligands used in the above reaction on a more complex substrate has been 
reported; note that the reactions had to be carried out at 50 oC; at a lower temperature the fully 
cyclised products were not formed (Figure 18).[38] Use of different catalyst enantiomers 
resulted in formation of diastereoisomeric products as would be expected from catalyst-control 
of the reactions. 
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TsHN HN
Ph Ph
+
NBoc
O
iPr
H2NN-Boc-L-Trp
O
O
O
MeO
H
15%
15%
O
O
MeO
H
BocN
O
O
50%
50 oC, 72h
TsHN HN
Ph Ph
iPr
H2NN-Boc-L-Trp
15%
15%
O
O
MeO
H
BocN
O
O
80%
50 oC, 72h
Figure 18. N’-Alkylated TsDPEN derivatives used to functionalise a complex enone substrate.
A squaramide-sulfonamide was applied to control a series of vinylogous aldol reactions.[39] 
A number of catalysts were tested and of these the TsDPEN-derived 25 gave a product of 92% 
ee in initial screening (Figure 19). The presence of the sulfonamide was shown to be critical 
for the high selectivity. However an alternative catalyst, bearing a single substituent on the 
diamine side chain, gave better results and was selected for further optimisation and successful 
application to a wide range of substrates. 
NH
N
H
Ph
Ph O
O
HN N
N
MeO
CHO
DCM, rt, 48 h
53% yield, anti:syn 80:20,
92% ee(anti)
S
O2
CF3
F3C
10 mol%
O
O+
O
O
OH
Cl Cl
25
Figure 19. Squaramide-based catalyst used in the asymmetric addition of cyclic lactone to an 
aldehyde.
The use of arene/Ru/TsDPEN to catalyse addition of acetylacetate to cyclic enones has been 
described. Alongside unfunctionalised TsDPEN, which gave the best results, were tested N’-
MeTsDPEN and other asymmetric catalysts.[40] A very wide range of TsDPEN derivatives 
were also tested in the addition of a -ketoester to nitrostyrene however the best one was 
TsDPEN itself and this was applied to a range of additions.[41] 
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5. Use of N-alkylated TsDPEN in Lewis acid-catalysed additions.
In a very recent paper[42], a complex of cobalt with ligand 26 was effective at the control of 
asymmetric additions of cyclic beta-ketoesters to nitrostyrene (Figure 20) in 91-98% ee. A 
variety of metals were tested, with cobalt (II) giving the best results and subsequent 
optimisation with respect to solvent and ratios of reagents delivering a system which was very 
efficient and enantioselective, even at 1 mol%. On the basis of a detailed mechanistic study 
and molecular modelling, the intermediacy of a bimetallic complex such as 27 in the catalytic 
cycle is speculated.
O
CO2Et
Ph
NO2+
O
CO2Et
NO2
Ph
0 oC, DCE
1 mol%
3 mol% Co(acac)2
40 mol% N-methyl
morpholine
HNNH
NHTs TsHNPh
PhPh
Ph
OH
HNNH
N
Ts
N
Ts
Ph
PhPh
Ph
O
Co Co
O
O
OEt
27
26
Figure 20. Co(II)-catalysed addition of cyclic ketone to nitrostyrene.
A similar catalyst, based this time on Ni(II) and for Mannich addition to imines (Figure 21) has 
proved to be highly effective.[43] In this case, the best of the ligands, 28, contained a p-
nitrophenylsulfonamide substituent on each of the two DPEN units and a bridging phenol group 
was essential to the operation of the catalyst. In this case a Ni(II) metal is used and again a 
bimetallic complex is anticipated to be the active catalyst. 
+
1 mol% 28
HNNH
NH HNPh
PhPh
Ph
OH
SO2Ar
SO2Ar
Ar=p(NO2)C6H4
CO2EtEtO2C NPh
Ts Ph
CO2Et
NHTs
CO2Et2 mol% Ni(OAc)2
92% yield, 97% ee
Figure 21. Asymmetric catalysis of addition of diethylmalonate to an imine.
6. Use of N-acylated TsDPENs in asymmetric organocatalytic reactions.
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Of a series of organocatalysts tested, 29a proved to be the most effective one for the formation 
of highly enantiomerically-pure 3-aminodihydrocoumarin products containing tertiary amine 
derivative groups which would otherwise be very difficult to prepare (Figure 22).[44] Using 5 
mol% catalyst, the cascade reaction could be scaled up to a gram scale for one example. 
O
N
O
Bn
+ -60 oC, THF
10 mol% 29q
N NHSO2(2,6-di(F)C6H3)
Ph Ph
O
O
N
CyN
NCy
H
Ph
O2N
Bn
NHCOPh
OOH
NO2
X X
Wide range of substrates
80-99% yield, 91-96% ee,
dr>19;1 in each case.
Figure 22. Guanidine catalyst used in asymmetric additions to nitrostyrene derivatives.
Another use of an analogous catalyst was reported for the synthesis of spirooxindoles using 
almost same catalyst. Following optimisation, a range of substrates were asymmetrically 
cyclised using catalyst 29b under mild conditions (Figure 23).[45] This included substrates 
which contain an NHTs in place of the OH of the side chain of the amide substrate.
-10 oC, 22 h, THF
5 mol% 29b
N NHSO2(2,4,6-tri(iPr)C6H2)
Ph Ph
O
N
CyN
NCy
H
70% yield, dr 11.5:1, e.r. 95:5 (major
diastereoisomer)
O
+
N
H
OH
O
N
H
O
O Ph
O
Figure 23. Spirooxindole synthesis using catalyst 29.
A cyclisation was also reported with an analogous ligand type to that described above, resulting 
in the formation of cyclohexanes through a Michael-Henry reaction sequence which created 
six stereogeneic centres in one step.[46] 
A further example of the same class of catalyst, in this case 30, was used to control the 
asymmetry of additions of alkynes to isatins to create a new chiral centre has been reported. 
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Products with ees of up to 96% were formed in this addition reaction (Figure 24).[47] A 
TsDPEN derived catalyst also promoted the reaction in 87% yield and 82% ee. 
CuI, 2,4,6-collidine
10 mol% 30
N NHSO2(2-napthyl)
Ph Ph
O
N
CyN
NCy
H
ee up to 96%,
up to 98% yield
N
H
O
O
N
H
O
HO Ph
1.2 eq. Ph
Figure 24. Asymmetric addition of alkynes to isatins.
7. Use of N-thiourea TsDPEN derivatives in asymmetric catalysis.
TsDPEN-based, thiourea-containing reagents have proved to be very successful as 
organocatalysts in a number of reactions. Wang has published several papers on diverse 
applications using 31 (which has come to be described by other researchers as ‘Wang’s 
ligand’). Ligand 31 has emerged as one of the best of a series generated and tested in the 
reaction of acetylacetone with nitrostyrene derivatives (Figure 25).[48] The catalyst was 
optimised with respect to the sulfonamide group, with the bis-(trifluoromethyl) being the 
optimal choice. The catalysts are understood to operate through an interaction of the 
thiourea/TsDPEN component with the nitro function and a hydrogen bonding interaction of the 
tertiary amine with the nucleophilic enol intermediate. These interactions co-operate to direct 
the reagents together in a controlled and selective manner. 
rt, Et2O, 1-2h
N HN
Ph Ph
H
N
H
S
NMe2
SO2
CF3
F3C
NO2
O O
+
NO2
O O
1 mol%
R R
up to 97% yield,
95-99% ee.
31
Figure 25. Wang’s ligand (31) applied to asymmetric additions to nitrostyrene.
Wang also reported the use of ligand 31 to direct the addition of -substituted--ketoesters to 
nitroolefins, giving products in up to 84% ee.[49] However in this case it was found that a more 
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effective catalyst could be produced by replacing the sulfonamide group with a hydroxyl group, 
resulting in improved diastereoisomeric ratios and ees in these cases. 
Ligand 31 was successfully applied to the control of the addition of nitroalkanes to nitroalkenes 
(Figure 26).[50] Using 10 mol% of the catalyst, at low temperature, an excellent level of 
versatility was demonstrated and products were formed in drs as high as 98:2 and in 99% ee in 
the best cases. Once again the tests indicated that the sulfonamide containing the two 
trifluoromethyl groups on the phenyl ring was the most selective one in this application, 
presumably reflecting the importance of the hydrogen-bonding interactions in the transition 
state for the addition (a catalyst containing an N-methylated sulfonamide led to no product). In 
one case the addition of 2-methyl-nitroethane was evaluated, giving an addition product in 88% 
yield and 64% ee. A range of aromatic groups could be tolerated (o-, m- and p- substituents as 
well as furyl and cinnamyl groups), and there was some scope for variation from nitroethane, 
with nitropropane and 2-phenylnitroethane also working well. 
DCM, -30 oC
N HN
Ph Ph
H
N
H
S
NMe2
SO2
CF3
F3C
NO2
R1
NO2
+
NO2
NO2R1
10 mol%
R R
R1=Me, R=H
87% yield,
98:2 dr
97% ee
H31
Figure 26. Diastereo- and enantioselective addition to nitrostyrenes.
In a further paper in 2010, catalyst 31 was once again found to be the best one of a series for 
the control of the addition of -aryl substituted cyclopentanones to nitroolefins.[51] This 
reaction generates two diastereoisomers as is the case with other additions, and however the 
addition is highly diastereoselective, and products with ees as high as 95% were generated for 
a wide range of substrates.
Xiao et al. tested a range of thiourea catalysts for activity in the addition reactions of thiols to 
a multi-unsaturated substrate, the thiourea being established as an excellent reagent for the 
activation of unsaturated nitro reagents. Once more, it was catalyst 31 that emerged as the best 
of the series tested (Figure 27).[52] In this reaction, a remarkable series of reactions takes place 
in a cleverly-designed sequence. Control of the initial addition of thiophenol to the nitroalkene 
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is critical and this is controlled by the catalyst thiourea group and associated hydrogen bonds. 
The diastereoselectivity of the subsequent cyclisation step results in formation of a complex 
ring system in a one pot process, which forms the basis of an efficient chroman ring synthesis. 
In further studies, triazoles and also anilines were found to be suitable replacements for the 
thiophenol in the addition step, giving products in ees of 92% and 86% respectively. A reaction 
at rt with 3 mol% 31 for 12h gave a product of 91% yield and 90% ee. 
DCM, 0 oC
N HN
Ph Ph
H
N
H
S
NMe2
SO2
CF3
F3C
NO2
3 mol%
48h, 70% yield
91% ee
dr >95:5
O OEt
O
SH
+
O
S
NO2
OEt
O
31
Figure 27. Addition/cyclisation reactions catalysed by 31.
The theme of thiophenol addition to unsaturated esters was extended by Wang et al in 2011, 
with a description of the use of catalyst 31 to control the addition of thiols to 4,4,4-
trifluorocrotonates in high ees; up to 95%.[53] The addition products could be cyclised to 
thiochromanones in high yield. One of the products is a key intermediate of the inhibitor of 
MMP-3, (R)-γ-trifluoromethyl γ-sulfone hydroxamate. Wang also described the use of 31 
successfully in the related additions of thiols to unsaturated esters containing a heavily 
fluorinated group in the ester.[54] The method can be adopted to synthesise an antidepressant 
agent, thiazemin.
A series of efficient asymmetric addition reactions of this to trifluorocrotonyl pyrazoles were 
also reported, similar to and related to the one above (53). Again it was catalyst 31 which 
proved to the most effective of those tested (Figure 28).[55]
Toluene, rt, <10min.
N HN
Ph Ph
H
N
H
S
NMe2
SO2
CF3
F3C
5 mol%
F3C N
O
+
N F3C N
O
N
RS
RSH
R is usually aromatic
yields >90%, ees up to 97%,
99% after recrystallsiation.31
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Figure 28. Asymmetric catalysis of thiol additions.
Thioadditions continue to be strong theme and a line of productive research using catalyst 31. 
In a 2013 paper, Wang described a desymmetrisation process through additions to spirocyclic 
oxindoles.[56] A further application of catalyst 31 was to the control of the addition of cyclic 
ketoesters to diethyl azodicarboxylate, representing an efficient method for the amination of 
the ketoester.[57] In this process, using up to 10 mol% of catalyst, the addition product was 
formed in up to 95% yield and 95% ee, at -78 oC. Again the multiple hydrogen bonding 
organocatalyst is able to strongly control the direction of the addition reaction. In the addition 
of a curcumin derivative to nitrostyrene, ligand 31 was reported to give an ee of 81% however 
an improved result was obtained in this instance by a closely-related organocatalysts containing 
a quinine group complimenting the TsDPEN /thiourea unit, in which case the conversion and 
ee could be pushed to 97 and 96% respectively.[58] An excellent result was obtained for a 
challenging addition/spirocyclisation which formed four contiguous stereocentres in one 
operation using catalyst 31 however (Figure 29).[59]
N HN
Ph Ph
H
N
H
S
NMe2
SO2
CF3
F3C
N
H
O
S
NO2
Toluene/DCM, rt, 0.5 h
76% yield
dr >20:1
94% ee
+
N
H
O
Ph
O
Ph
S
Ph
NO2
OH
Ph
31 BrBr
10 mol%
Figure 29. Four contiguous stereocenters formed by a one-pot Michael-Henry-cascade-
rearrangement reaction.
Xiao et al. reported an intramolecular crossed Rauhut-Currier reaction using thiourea 32, which 
emerged as the optimal catalyst of those tested.[60] In this case the initial addition of the 
CBzNHOBoc reagent was followed by its elimination to leave an unsaturated product with a 
single chiral centre in an ee as high as 92% (Figure 30). The reaction had to be run at low 
temperature in order to achieve the highest ee, at the cost of an extended reaction time. The 
reaction was applied to a range of substrates.
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CHCl3. -40 oC for one day,
-20 oC for five days.
N HN
Ph Ph
H
N
H
S
NMe2
SO2
NO2
20 mol%
92% yield, 92% ee
O OEt
O
O
NO2
OEt
O
1.2 eq. CBzNHOBoc
32
Figure 30. Intramolecular crossed Rauhut-Currier reaction catalysed by 32.
Shao et al., in 2016, found that catalyst 33 was ideal for the control of the addition reaction of 
an alkynone to nitrostyrene (Figure 31).[61] The activating group in the substrate was removed 
by careful treatment with acid at the end of the reaction; using a larger amount (2 eq) of TsOH 
resulted in formation of a -diketone. Extending the range of substrates was successful, with 
the most selective reactions giving products in up to 97% ee. In the mechanism, once more the 
thiourea forms a critical bond to the nitro group, with the direction of nucleophilic addition 
speculated to be directed by the other functional group via a series of hydrogen bonds. 
N NHTs
Ph Ph
H
N
H
S
NMe2
10 mol%
Ph
NO2
DCM, rtPh
O
OtBu
O
i)
ii) 0.2 eq. TsOH, H2O
toluene, 110 oC
Ph
O Ph
NO2
85% yield, 96% ee.
33
Figure 31. Asymmetric addition and decarboxylation.
Shi et al. reported a highly enantioselective cyclisation of 3-isothiocyanato oxindoles with 
trifluoromethylated 2-butenedioic acid diesters promoted by organocatalyst 34, which was the 
best ligand of a series used in the cycloaddition (Figure 32).[62] A wide range of functional 
groups are tolerated in the reaction, making it very versatile.
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TsHN HN
Ph Ph
HN N
N
MeO
N
R
O
NCS
BnO2C
CF3EtO2C N
R
O
R2 R2 HN
CO2Et
CO2Bn
S CF3
20 mol%
Toluene, rt, 12h
dr typically 20:1
ee from 90-96%
S
34
Figure 32. Enantioselective [3+2] cycloaddition.
The N-mesylated ligand containing a quinine group, 35 (similar to that used in Figure 32), was 
found to be effective at the control of the addition of 3-aryloxindoles to phenylvinylsulfone 
(Figure 33).[63] This represents a very elegant example of the ability of the modified thiourea 
to control additions to sulfones, presumably also through multiple hydrogen bonding 
interactions.
N
Boc
O
Ph
SO2Ph Toluene/CHCl3, -20 oC,
86% yield
94% ee
+
MsHN HN
Ph Ph
HN
N
N
MeO
S
N
Boc
O
Ph
PhO2S
20 mol%
35
Figure 33. Asymmetric Michael addition of 3-aryloxindoles to phenyl vinyl sulfone.
TsDPEN derivatives were one of a series in an addition reaction of aryloxazoles to a 1-1-
diphosphate ethene but was not the best of those tested.[64] The best catalyst was similar to 
the one used in Figure 33 but with a ArNH in place of the TsDPEN unit.
The reactions of isatins with isocyanoacetates have been studied using TsDPEN-containing 
thioureas as catalysts. Catalyst 35 was the best of a series tested in this application (Figure 
34).[65] In this case the isocyanate formed the basis of a second ring fused in a spiro fashion 
and under optimised conditions a good level of stereocontrol. Multiple hydrogen bonding 
interactions are again likely to be responsible for control of absolute stereochemistry here, and 
better results were obtained with some of the substituted substrates.
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N
R
O
O
NC
SO2Ph Et2O, 20 oC, 24h
+
MsHN HN
Ph Ph
HN
N
N
MeO
S
N
Bn
O
10 mol%
Ph
O
N
Ph
R=H 93% yield, >20:1, 80% ee
R=Bn 74% yield, 12:1 dr, 86% ee
R=Me 69% yield, 14:1, 77% ee
R=Ph 95% yield, 20:1, 70% ee
PhO2S35
Figure 34. Asymmetric cycloaddition reaction of isocyanoacetates to isatins.
Catalyst 35 once again proved effective in an asymmetric application – in this case the reaction 
of alpha-cyano ketones with isatylidiene malononitriles (Figure 35).[66] In this case the 
cascade cyclisation took place to form the heterocyclic product in remarkably high ees. The 
initial screening with the N-benzylated malononitrile gave a product of 72% but then switching 
to the N-methylated derivative with the addition of 1 mol% of morpholine at lower temperature 
raised the ee to 90%. The application was applied to a wide range of substrates, all of which 
gave products in very high yields of typically 98-99% and with ees as high as 97% in the best 
cases. 
N
Me
O
O
1 mol% morpholine
DCM, -10 oC
+
MsHN HN
Ph Ph
HN
N
N
MeO
S
N
Bn
O
2 mol%
Ph
98% yield, up to 90% ee
NC
CN
CN
O
Ph
CN
H2N
NC
35
Figure 35. Asymmetric synthesis of spiro[4H]-pyran-oxindoles.
Ligand 36 was optimised for use in addition to isatins (Figure 36).[67] There was a very 
interesting and unexpectedly positive effect from the addition of methanol. This was applied 
to a good range of targets and extended to acyclic alpha-keto esters with related ligands, 
although further screening and optimisation revealed an alternative ligand to be the optimal 
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one – containing a squaramide linkage and a dialkylated DPEN unit rather than a 
TsDPEN.[67b]
N
PNB
O
O
NC
OEt CHCl3 rt 9h
+
NH HN
Ph Ph
HN
N
N
MeO
S
N
PNB
O
5 mol%
O
S
O2
CF3
F3C
NC O OEt
O
50% MeOH
up to 97% yield
up to 99% ee
R R
36
Figure 36. Asymmetric Cyanoethoxycarbonylation of Isatins.
For the conversion of oxime tosylates to cyclic azirines by an intramolecular process, 
TsDPEN/thioureas were but were not the best ones of the series tested.[68] The use of Wang’s 
catalyst gave a product in 72% yield and 56% ee however. Ligand 37 was used in 
enantioselective reactions of ketimine with a pyrazoleamide (Figure 37).[69] The first reactions 
allowed for Nosyl cat. to give 60% yield, 98:2 dr and 97% ee before the conditions were 
optimised. Under same conditions a tosyl derivative gave a product of 53% yield, 97:3 dr and 
96% ee.
N
R
O
NBoc
CH3CN, 4Å MS, 25 oC
+
NH HN
Ph Ph
HN
N
N
MeO
S
N
R
O
10 mol% S
O2
84-97% yields
up to dr 99:1 and >99% ee
R R
O2N
NHBoc
Ar
O
N
N
N
N
Ar
O
37
Figure 37. Enantioselective Mannich reaction of pyrazoleamides with isatins.
Thiourea 38, containing a 4-nitrophenylsulfonamide and an attached basic nitrogen 
functionality, did prove to be the optimal one tested in the enantioselective Michael addition 
of 5H-oxazol-4-ones to unsaturated ketones (Figure 38).[70] Compared to other related 
catalysts these were found to be more effective and they are derived from L-tert-leucine. 
Products were obtaining in >90% ee in the best cases. 
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DCM, 50 oC, 72h
N
H
NH
PhPh
N
H
S
O2S
10 mol%
up to 98% yield
>30:1 dr in most cases
>99% ee in the best cases.
O2N
N
N
O
O
R1
Ph
R2 R3
O+
N
O
O
R1
Ph
R3
OR238
Figure 38. Asymmetric Michael addition of 5H-oxazol-4-ones to -unsaturated ketones.
Peng et al. reported an intramolecular addition to a nitrostyrene to form a 1,2-diamine in high 
ee. The TsDPEN-containing catalysts gave good results but in these cases the best results were 
obtained with a 1,2-cyclohexyldiamine-containing catalyst.[71]
The enantioselective addition of simple ketones, including acetone and acetophenone, to 
nitroolefins can also catalysed by thiourea/TsDPEN catalysts. In this case a series of catalysts 
containing adjacent primary amine functionality were evaluated and tested in the application. 
Of these the compound containing a TsDPEN and a cyclohexyldiamine proved to be highly 
effective (Figure 39).[72] In this case the primary amine is believed to form an enamine with 
the ketone reagent whilst the thiourea and TsDPEN bind the nitro group, serving to hold both 
reagents in close proximity and within a well-defined transition state for the addition reaction. 
Evidence for this was provided by the non-reactivity of N’.N’-dimethylated catalyst i.e. which 
was unable to form the required enamine.
15 mol% PhCO2H, CHCl3
NH NHTs
Ph Ph
N
H
S15 mol%
NH2
Ph
N
+
O
R
Ph
NO2
O
R 71-87% yield
97-99% ee
N NTs
Ph Ph
N
S
NH
NH NHTs
Ph Ph
N
H
S
NMe2
No addition using this catalyst:
OO
H
H H
Ph
NO2
Ph
Proposed mode
of addition:
39
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Figure 39. Asymmetric addition of ketones to nitrostyrene.
In a related later report by Shao et al. in 2017, the enantiomeric catalyst was found to be 
efficient at directing the addition of acetophenone to a complex nitroalkene in a high ee of 97% 
(Figure 40).[73] In this reaction the diastereoisomer of the catalyst (i.e. 40, derived from (S,S)-
TsDPEN rather than the (R,R)-TsDPEN) was less efficient, as was the mesyl derivative of the 
catalyst and a phosphorylated derivative. 
15 mol% 4-(MeO)C6H4CO2H
DCM, rt, 96h
NH NHTs
Ph Ph
N
H
S15 mol%
NH2+
O
R
NO2
O
R
75% yield, 97% ee.
NO2
Ph
Ph
40
Figure 40. Asymmetric additions to nitrodienynes.
Compounds containing a combination of proline and TsDPEN have been applied to 
asymmetric aldol reactions.[74] Amide 41 (Figure 41) was one of a series of catalysts for an 
asymmetric aldol reaction reported by Zhao and Samanta in 2006, and gave a product of 33% 
ee.[74a] The proline is believed to form an enamine intermediate in a key step in the 
mechanism. Singh et al published a detailed study on the synthesis of all four diastereosiomers 
of the catalysts and their applications to the asymmetric aldol reactions of ketones with 
aromatic aldehydes.[75] All of the isomers were effective catalysts, giving the aldol product of 
cyclohexanone with 4-fluorobenzene in 92:8-91:9 diastereoisomeric ratios and 87-90% ee, 
indicating that the proline residue was having the major effect and the TsDPEN unit a 
moderating one on the overall selectivity. Wills et al use a series of similar compounds for 
asymmetric transfer hydrogenation reactions of ketones; products of up to 90% ee were formed, 
with the proline component again dominating the selectivity but with a contribution from the 
TsDPEN unit.[76] 
NH NHTs
Ph Ph
O
NH
41
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Figure 41. Compound used in aldol reactions and transfer hydrogenations.
8. Miscellaneous asymmetric catalytic reactions using N’-alkylated or acylated TsDPEN 
derivatives.
Several papers have contained reports of the selective acylation of diarylmethyl compounds by 
acylation of a remote phenol, which is obviously a very challenging reaction. This has been 
achieved using a peptide or protein with a terminal amine group which acts as an acylation 
catalyst and in some of these applications some of the catalysts contain a TsDPEN 
functionality.[77,78,79,80] In the example in Figure 42, an optimised small peptide 42 was 
found to be highly effective at directing the reaction, as evidenced by the high ee obtained.[80] 
tBu
HO OH
tBu
HO OAc
up to 95% ee
Ac2O
N
NMe
BocHN
H
N
N
HO
NHR
O
O
H
N
O
N
H
O
OtBu
Ph
NHTs
Ph
42
Figure 42. Enantioselective remote acylation using a peptide catalyst.
In a very interesting application, an N-aryl TsDPEN derivative 43 was used to create a catalyst 
with a helical chirality which then acts to efficiently direct the asymmetric condensation of 
aldehydes with the phenol shown in Figure 43.[81]
OH DCM, -90 oC
N
Ph
NSO2CH2Ar
Ph
N
O
N
R
+ RCHO
O
CF3
N
Ph
ArH2CO2SN
Ph
O
CF3
P
2 mol%
87-99% yield
87-96% ee
R R43
Figure 43. Asymmetric catalysis using a hexacoordinated chiral phosphate ion.
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Building upon excellent results using silyl chloride reagents to promote asymmetric reactions, 
Leighton et al. reported the use of a silicon-based catalyst 44 for the asymmetric Diels-Alder 
reaction between methacrolein and cyclopentadiene in up to 37% ee (Figure 44).[82] However 
the analogous cyclohexyl diamine-derived ligand was better in this case, giving a product of 
94% ee (20 mol% catalyst, DCM, -78 oC, 8h). 
N
44
Si
Ph
Ph
Ts
N
O
Cl
tBu
tBu
Figure 44. Catalyst used in Diels-Alder reaction catalysis.
Some applications have been reported in which a N’-functionalised TsDPEN-derived catalyst 
was tested but was not the best in the application. In an indole functionalisation [83] a TsDPEN 
gave a product of only 23% ee and lower than for an analogous catalysts containing the 
cyclohexyldiamine backbone structure. A DPEN –based catalyst 45 was used in a 1,3 dipolar 
cycloaddition (Figure 45). The best ligand however contained a iBu group in place of the Ts 
group, and gave a product of 98% ee.[84]
EtO2C+ Ag+ catalyst
toluene , rt
CO2Et
Ph N CO2Me EtO2C
CO2Et
NH
CO2Me
Ph
major
86% yield, 78% ee after 21 h.
N
H
45
Ph
Ph NHTs
O
H
N
Ph O
Ph2P
4 mol%
Figure 45. Asymmetric 1,3 dipolar cycloaddition using a TsDPEN-based ligand.
In the addition of acrylonitrile to nitrostyrene, a cross Rauhut-Currier-type, Wang’s catalyst 
was evaluated and gave a product in 68% yield and 45% ee after 12 h.[85] A TsDPEN ligand 
is one in a series used in an asymmetric hydrosilylation of an imine in up to 90% ee with best 
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catalyst the TsDPEN example gave 92 yield/82% ee but the best were around 93-94% ee.[86] 
Addition of an indole to 2-amino-4H-chromenes where a TsDPEN-containing ligand was one 
of several studied but not the best. The best contained a simple di-meta-
(CF3)benzylsulfonamide group in place of the TsDPEN.[87]. The addition of alpha-amino 
aldehydes to 3-indoylmethanols using an enamine catalysts. TsDPEN-containing tested but not 
the best one – an OH-containing (in place of the NHTs) was the best one in this application.[88] 
TsDPEN catalysts were used in reactions of nitromethane derivatives in additions to enones. A 
simpler thiourea catalyst, containing a valinol-derived, tosylated diamine in place of the 
TsDPEN unit, was the best of the series tested.[89] Derivatives of TsDPEN have also featured 
in several catalysts based on the dppf scaffold.[90,91,92]
9. Conclusions.
In this review, we have highlighted the rich diversity of reagents which have been prepared 
from a single readily-available enantiomerically-pure building block and their numerous 
applications in asymmetric catalysis. In many cases, the TsDPEN-derived ligands and catalysts 
have proved to be the most effective of a series that were tested. Even after the development 
of a large number of reagents and applications, there is clearly still significant potential for 
further applications of TsDPEN derivatives to asymmetric catalysis, and no doubt further 
exciting developments will soon be reported. 
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